VJHemOnc is committed to improving our service to you

MDS 2020 | EPO plus G-CSF treatment for MDS

VJHemOnc is committed to improving our service to you

Nicolas Bonadies

Nicolas Bonadies, MD, Bern University Hospital, Bern, Switzerland, discusses the efficacy of combining granulocyte-colony stimulating factor (G-CSF) with erythropoietin (EPO) for low-risk myelodysplastic syndrome (MDS) patients. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter